{"schema_version":"secwatch.filing_event.v1","accession":"0001459839-23-000102","form_type":"8-K","ticker":"SIBN","cik":"0001459839","company_name":"SI-BONE, Inc.","filed_at":"2023-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.130427+00:00","generated_at":"2026-06-08T19:38:39.971870+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"SI-BONE reports Q3 2023 record revenue of $34.0M (+29% YoY); raises FY23 guidance to $136-137M","bullets":["Q3 revenue $34.0M (+29% YoY); US revenue $32.3M (+31% YoY).","Net loss improved to $10.0M ($0.25/sh) from $14.2M ($0.41/sh) YoY.","Adjusted EBITDA loss improved 44% to -$3.9M.","Raised fiscal 2023 revenue guidance to $136M-$137M from $132M-$134M.","Over 1,040 US active surgeons (+30% YoY); 90,000 procedures worldwide."],"urls":{"canonical":"https://secwatch.observer/filing/0001459839-23-000102","json":"https://secwatch.observer/filing/0001459839-23-000102.json","markdown":"https://secwatch.observer/filing/0001459839-23-000102.md","text":"https://secwatch.observer/filing/0001459839-23-000102.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1459839/000145983923000102/0001459839-23-000102-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1459839/000145983923000102/sibn-20231106.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T19:38:39.971870+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ad36c945e9a041d60338323f03b344b4700a732a","claim":"SI-BONE, Inc. reported the quarter ended September 30, 2023 results: revenue $34.0 million, net income $10.0 million, or $0.25 per diluted share, EPS $0.25 per diluted share. Guidance raised.","evidence_excerpt":"disorders of the sacropelvic anatomy, today reported financial results for the quarter ended September 30, 2023. Recent Financial Highlights • Record worldwide revenue of $34.0 million for the third quarter 2023, representing approximately 29% growth over the corresponding period in 2022 • Record U.S. revenue of $32.3 million for the third quarter 2023,","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1459839/000145983923000102/0001459839-23-000102-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended September 30, 2023"},{"label":"Revenue","value":"$34.0 million"},{"label":"Net income","value":"$10.0 million, or $0.25 per diluted share"},{"label":"EPS","value":"$0.25 per diluted share"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}